tirzepatide 4 mg tirzepatide/pyridoxine 22 mg-4 mg/ml 10mg (10mg/mL + B6 10mg/mL) (1mL Vial) Formiv Tirzapetide 15mg
Description
Today we announced positive topline results from the first Phase 1b clinical trial of elecoglipron conducted in China in adults living with obesity/overweight, with or without type 2 diabetes

Adults with overweight or obesity taking the once-weekly GIP/GLP-1 receptor agonist tirzepatide achieved a mean weight loss of at least 16% at 72 weeks, according to topline results from the SURMOUNT-1 clinical trial

Vanessa Mack (Dean)

A sub-analysis comparing the two intervention cohorts was also performed

East Bay Functional Medicine Specialist, Audra Foster, N.D

Learn which nutrients to pay attention to, including vitamin D, B12, omega-3, magnesium, zinc and collagen.
